Skip to content

The Effect of Holy Qur’an Recitation on the inflammatory factors

The Effect of Holy Qur’an Recitation on the inflammatory factors in Hemodialysis Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120109008665N9
Enrollment
50
Registered
2019-11-04
Start date
2019-11-22
Completion date
Unknown
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease. Chronic kidney disease, stage 5

Interventions

Intervention 1: Intervention group: Music therapy intervention on the experimental group are done according to the prepared protocol based on similar studies. The aim of music therapy in this study is

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Willingness to listen to the Holly Quran Consent to participate in the study Age range 20 to 65 years At least six months of treatment with hemodialysis Consciousness having hemodynamic stability No history of recent infection (recent 3 months) The lack of serious psychiatric problems Obtain Score 10 for the anxiety and 7 for the depression items of the Hospital Anxiety and Depression Scale (HADS) No history of long-term use of corticosteroids and immunosuppressive drugs

Exclusion criteria

Exclusion criteria: left handed Hearing impairment Reciter of Quran Arabic speaking patients

Design outcomes

Primary

MeasureTime frame
Level of the inflammatory factor (IL6). Timepoint: Before intervention and one month later. Method of measurement: Using an ELISA kit for measuring human IL-6, product of Diaclone France.;Level of the inflammatory factor (Erythrocyte Sedimentation Rate). Timepoint: Before intervention and one month later. Method of measurement: ESR measurement using ESR tube containing sodium citrate solution, Product of Teb Shahr Company.;Level of the inflammatory factor (C Reactive Protein). Timepoint: Before intervention and one month later. Method of measurement: CRP measurement, using ELISA, Using the XL Selectra device, a product from the Netherlands.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHassan Babamohamadi

Semnan University of Medical Sciences

babamohammady2007@gmail.com+98 23 3365 4192

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026